Printer Friendly

Board of directors meeting of GlaxoSmithKline Consumer Healthcare Pakistan Limited.

Karachi -- GlaxoSmithKline Consumer Healthcare Pakistan Limited informed Pakistan Stock Exchange that board of directors meeting of the company will be held on August 27, 2019 at Karachi. The agenda of the meeting will to consider the Half Yearly Accounts for the period ended June 30, 2019.

Further, the company has declared the closed period from August 20, 2019 to August 27, 2019.

The announcement is available at:

https://dps.psx.com.pk/download/image/133514-1.gif

GlaxoSmithKline Consumer Healthcare Pakistan Limited was incorporated in Pakistan as a public unlisted company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017). The Company is a subsidiary of GlaxoSmithKline Consumer Healthcare B.V. The ultimate parent of the Company is GlaxoSmithKline plc, UK. The Company is engaged in manufacturing, marketing and sale of consumer healthcare products.

COPYRIGHT 2019 Knowledge Bylanes
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Pakistan Company News
Geographic Code:9PAKI
Date:Aug 20, 2019
Words:171
Previous Article:Financial results of Engro Corporation Limited for Quarter ended June 30, 2019.
Next Article:Financial results of Allied Bank Limited for Quarter ended June 30, 2019.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |